⚖️ Navigating GLP-1 Weight Loss: Diet, Exercise, and Well-being
This patient-focused guide from JAMA Internal Medicine provides essential information for individuals utilizing GLP-1 medications for weight loss. It outlines the medications’ functions and offers practical dietary advice through a “MEAL” plan, emphasizing muscle maintenance, energy balance, side effect avoidance, and adequate liquid intake. Furthermore, the document provides exercise recommendations to preserve muscle mass and overall health, and it suggests strategies for preventing weight regain if medication is […]
ADA 2025: Clinical Trial Data on Incretin Therapies
Dr Anne Peters discusses recent data on novel incretin therapies and combinations. Medscape Diabetes & Endocrinology
GLP1 weight loss injections may reduce asthma symptoms
GLP1 agonist drugs, commonly known by brand names such as Ozempic and Mounjaro, reduce asthma symptoms in obese people according to a new study from the University of Aberdeen and the Observational and Pragmatic Research Institute (OPRI), Singapore.
GLP-1s Only Opening Act: Experts Unveil Diet-Exercise Guide
Experts highlight interventions to support muscle and nutrient preservation during GLP-1 treatment and offer practical strategies to manage side effects in a new ‘Clinical Insights’ article. Medscape Medical News
STAT+: European regulators endorse Lilly’s Alzheimer’s treatment for certain patients
European regulators on Friday said that Eli Lilly’s Alzheimer’s treatment Kisunla should be approved for a select group of patients, changing course from an initial recommendation to reject the drug. A European Medicines Agency committee ruled in March that the risks of the therapy — namely a type of brain swelling and bleeding known as […]
Weight loss jabs could be key to controlling asthma in thousands of Brits, say scientists
WEIGHT loss jabs could help control asthma symptoms in obese people, a study suggests – and it’s not just about losing weight. The drugs should be explored as a potential treatment for obese people with asthma, who are “often resistant” to steroids, researchers said. GettyAsthmatic people who used weight loss jabs had less severe symptoms […]
Germin-like protein 1 interacts with proteasome regulator 1 to regulate auxin signaling by controlling Aux/IAA homeostasis
Xu et al. reveal a non-canonical mechanism that transduces the membrane-to-nucleus signal of auxin independent of the TIR1 pathway, uncovering a new layer of regulation in auxin signaling. Auxin promotes the GLP1-PTRE1 interaction, leading to PTRE1 retention at the plasma membrane and suppression of nuclear proteasome activity, thereby stabilizing Aux/IAA repressors.
Scientists discover how you can turn on your body’s natural Ozempic to lose weight without the nasty side effects
Researchers from Duke University have discovered the unique system in your gut that naturally mimics the effects of GLP-1 drugs’ appetite-suppressing quality in the body and can help control weight gain.
GLP-1 receptor agonist use linked to lower mortality in seniors with cancer, T2D
For older patients with cancer and type 2 diabetes (T2D), glucagon-like peptide-1 receptor agonist (GLP-1 RA) use is associated with lower all-cause mortality than dipeptidyl peptidase-4 inhibitor (DPP4i) use, according to a study published online July 18 in JAMA Network Open.
Could GLP-1 drugs drive a reduction in package sizes?
A new analysis of the popular weight-loss drugs suggests a pivot from CPG companies to smaller food products